Details for 2020710607
Up to date per 01.04.2026
Actions
Details for 2020710607
Granted/Registered
European Patent
05.01.2022 A
08.05.2024 B1
27.02.2019
US
201962811009 P
A61K 31/4412 20060101AFI20200904BHEP
Owner
Astrazeneca AB 151 85 SödertäljeSE
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.Hansastr. 27c 80686 MünchenDE
Representative
No representatives present
Inventor
COUSENS, LeslieAstraZeneca Pharmaceuticals LP 35 Gatehouse Drive Waltham, Massachusetts 02451US
NIVENS, ChadAstraZeneca Pharmaceuticals LP 35 Gatehouse Drive Waltham, Massachusetts 02451US
ESCOTT, Katherine JaneAstraZeneca UK Limited 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AAGB
MONKLEY, SusanAstraZeneca AB Pepparedsleden 1 MölndalSE
PRASSE, AntjeFraunhofer-Gesellschaft zur Forderung der Angewandten Forschung E.V. Hansastraße 27c MünchenDE
Information about Fees